Lixisenatide (Adlyxin in U.S., Lyxumia in EU): (EU approval 2013, US in 2016)
Trial and therapeutic categorization As of January 31, 2024, we downloaded records of 179 active interventional clinical trials meeting our search criteria from the ClinicalTrials.gov website
Its important to tell your Ro-affiliated provider all of the medications you are currently taking, including prescription, over-the-counter medications, vitamins, and herbal and dietary supplements
Case reports described by Drucker and colleagues link GLP-1 use to acute pancreatitis, although a direct cause-and-effect relationship hasnt been definitively established
The overall percentage of firms with 200 or more workers that cover GLP-1 agonists for weight loss (19%) is similar to the percentage last year (18%)